TβR-II, a gene known to possess the cancer-combating properties participating as part of the TGF-β signaling cascade [39] and its decreased expression are associated with in contrarily, pancreatic cancer lack of term due to mutations h the malignant transformation of tumours. This evidence concerns the gene TGFB1 and neoplasm.